Fabrice Egros joins Xanodyne as COO
This article was originally published in Scrip
Executive Summary
Xanodyne Pharmaceuticals has appointed Fabrice Egros chief operating officer, reporting to president and CEO Natasha Giordano. Mr Egros has more than 20 years' experience in the pharmaceutical industry,having previously served in various senior positions at UCB Pharmaceuticals.